Wilmot Cancer Institute

Associate Professor of Medicine Erika Ramsdale ’21 (MS) discusses what AI can—and can’t—teach doctors about connection.

A special yoga intervention goes a step further than other therapies to address the side effects that most cancer patients experience.

Glutathione, a common antioxidant supplement, may also act as a powerful fuel for cancer cells, according to new research from the Wilmot Cancer Institute.

What happens when you combine a determined doctor, a groundbreaking procedure, and an institution built to support the research behind complex medicine.

Rochester scientists discover that long-lived bats resist cancer thanks to strong immune systems and protective genes—findings that could offer new insights into human aging and disease prevention.

“It’s an extraordinary moment in the history of the cancer center,” says Wilmot Cancer Institute director Jonathan Friedberg.

The new classification places Rochester among the top 4 percent of cancer centers in the United States.

At a May meeting, the University Board of Trustees elected two new members, and recognized three members on becoming life trustees.

The new imaging system developed by Michael Giacomelli, an assistant professor of biomedical engineering and of optics, uses two-photon fluorescence microscopy (TPFM).

An internal funding program, plus the close proximity of the University’s engineering and medical facilities, promotes progress in a potential treatment for acute myeloid leukemia.